BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Melki I, Frémond M. Type I Interferonopathies: from a Novel Concept to Targeted Therapeutics. Curr Rheumatol Rep 2020;22. [DOI: 10.1007/s11926-020-00909-4] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 9.0] [Reference Citation Analysis]
Number Citing Articles
1 Saulescu I, Ionescu R, Opris-belinski D. Interferon in systemic lupus erythematosus—A halfway between monogenic autoinflammatory and autoimmune disease. Heliyon 2022. [DOI: 10.1016/j.heliyon.2022.e11741] [Reference Citation Analysis]
2 Raupov RK, Suspitsin EN, Imelbaev AI, Kostik MM. Simultaneous Onset of Pediatric Systemic Lupus Erythematosus in Twin Brothers: Case Report. Front Pediatr 2022;10:929358. [DOI: 10.3389/fped.2022.929358] [Reference Citation Analysis]
3 Batu ED, Sener S, Ozen S. COVID-19 associated pediatric vasculitis: A systematic review and detailed analysis of the pathogenesis. Semin Arthritis Rheum 2022;55:152047. [PMID: 35709649 DOI: 10.1016/j.semarthrit.2022.152047] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
4 David C, Frémond ML. [When to consider type I interferonopathy in adulthood?]. Rev Med Interne 2022:S0248-8663(21)01114-0. [PMID: 35177256 DOI: 10.1016/j.revmed.2021.11.003] [Reference Citation Analysis]
5 Skarlis C, Mavragani CP. Immune Dysfunction and Drug Targets in Autoinflammatory Syndromes. Comprehensive Pharmacology 2022. [DOI: 10.1016/b978-0-12-820472-6.00071-2] [Reference Citation Analysis]
6 Beck MA, Fischer H, Grabner LM, Groffics T, Winter M, Tangermann S, Meischel T, Zaussinger-Haas B, Wagner P, Fischer C, Folie C, Arand J, Schöfer C, Ramsahoye B, Lagger S, Machat G, Eisenwort G, Schneider S, Podhornik A, Kothmayer M, Reichart U, Glösmann M, Tamir I, Mildner M, Sheibani-Tezerji R, Kenner L, Petzelbauer P, Egger G, Sibilia M, Ablasser A, Seiser C. DNA hypomethylation leads to cGAS-induced autoinflammation in the epidermis. EMBO J 2021;40:e108234. [PMID: 34586646 DOI: 10.15252/embj.2021108234] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
7 Szekanecz Z, McInnes IB, Schett G, Szamosi S, Benkő S, Szűcs G. Autoinflammation and autoimmunity across rheumatic and musculoskeletal diseases. Nat Rev Rheumatol 2021. [PMID: 34341562 DOI: 10.1038/s41584-021-00652-9] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 24.0] [Reference Citation Analysis]
8 Rey-jurado E, Poli MC. Functional genetics in inborn errors of immunity. Future Rare Diseases 2021;1:FRD11. [DOI: 10.2217/frd-2020-0003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
9 Georgel P. Crosstalk between Interleukin-1β and Type I Interferons Signaling in Autoinflammatory Diseases. Cells 2021;10:1134. [PMID: 34066649 DOI: 10.3390/cells10051134] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
10 Frémond M, Nathan N. Syndrome COPA, quoi de neuf cinq ans après ? Revue du Rhumatisme 2021;88:183-189. [DOI: 10.1016/j.rhum.2021.02.018] [Reference Citation Analysis]
11 Fenaroli P, Rossi GM, Angelotti ML, Antonelli G, Volpi S, Grossi A, Delsante M, Lodi L, Landini S, Romagnani P, Vaglio A. Collapsing Glomerulopathy as a Complication of Type I Interferon-Mediated Glomerulopathy in a Patient With RNASEH2B-Related Aicardi-Goutières Syndrome. Am J Kidney Dis 2021:S0272-6386(21)00532-1. [PMID: 33872687 DOI: 10.1053/j.ajkd.2021.02.330] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
12 Granata T, Fusco L, Matricardi S, Tozzo A, Janigro D, Nabbout R. Inflammation in pediatric epilepsies: Update on clinical features and treatment options. Epilepsy Behav 2021;:107959. [PMID: 33867302 DOI: 10.1016/j.yebeh.2021.107959] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
13 Mura E, Masnada S, Antonello C, Parazzini C, Izzo G, Garau J, Sproviero D, Cereda C, Orcesi S, Veggiotti P, Zuccotti G, Dilillo D, Penagini F, Tonduti D. Ruxolitinib in Aicardi-Goutières syndrome. Metab Brain Dis 2021;36:859-63. [PMID: 33721182 DOI: 10.1007/s11011-021-00716-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
14 Frémond ML, Crow YJ. STING-Mediated Lung Inflammation and Beyond. J Clin Immunol 2021;41:501-14. [PMID: 33532887 DOI: 10.1007/s10875-021-00974-z] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 19.0] [Reference Citation Analysis]
15 Ambrosi A, Thorlacius GE, Sonesson SE, Wahren-Herlenius M. Interferons and innate immune activation in autoimmune congenital heart block. Scand J Immunol 2021;93:e12995. [PMID: 33188653 DOI: 10.1111/sji.12995] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
16 Lodi L, Melki I, Bondet V, Seabra L, Rice GI, Carter E, Lepelley A, Martin-Niclós MJ, Al Adba B, Bader-Meunier B, Barth M, Blauwblomme T, Bodemer C, Boespflug-Tanguy O, Dale RC, Desguerre I, Ducrocq C, Dulieu F, Dumaine C, Ellul P, Hadchouel A, Hentgen V, Hié M, Hully M, Jeziorski E, Lévy R, Mochel F, Orcesi S, Passemard S, Pouletty M, Quartier P, Renaldo F, Seidl R, Shetty J, Neven B, Blanche S, Duffy D, Crow YJ, Frémond ML. Differential Expression of Interferon-Alpha Protein Provides Clues to Tissue Specificity Across Type I Interferonopathies. J Clin Immunol 2021;41:603-9. [PMID: 33411153 DOI: 10.1007/s10875-020-00952-x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
17 Yang E, Li MMH. All About the RNA: Interferon-Stimulated Genes That Interfere With Viral RNA Processes. Front Immunol 2020;11:605024. [PMID: 33362792 DOI: 10.3389/fimmu.2020.605024] [Cited by in Crossref: 30] [Cited by in F6Publishing: 33] [Article Influence: 15.0] [Reference Citation Analysis]
18 Frémond ML, Hadchouel A, Berteloot L, Melki I, Bresson V, Barnabei L, Jeremiah N, Belot A, Bondet V, Brocq O, Chan D, Dagher R, Dubus JC, Duffy D, Feuillet-Soummer S, Fusaro M, Gattorno M, Insalaco A, Jeziorski E, Kitabayashi N, Lopez-Corbeto M, Mazingue F, Morren MA, Rice GI, Rivière JG, Seabra L, Sirvente J, Soler-Palacin P, Stremler-Le Bel N, Thouvenin G, Thumerelle C, Van Aerde E, Volpi S, Willcocks S, Wouters C, Breton S, Molina T, Bader-Meunier B, Moshous D, Fischer A, Blanche S, Rieux-Laucat F, Crow YJ, Neven B. Overview of STING-Associated Vasculopathy with Onset in Infancy (SAVI) Among 21 Patients. J Allergy Clin Immunol Pract 2021;9:803-818.e11. [PMID: 33217613 DOI: 10.1016/j.jaip.2020.11.007] [Cited by in Crossref: 38] [Cited by in F6Publishing: 40] [Article Influence: 19.0] [Reference Citation Analysis]
19 Frémond ML, Nathan N. COPA syndrome, 5 years after: Where are we? Joint Bone Spine 2021;88:105070. [PMID: 32919065 DOI: 10.1016/j.jbspin.2020.09.002] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 5.5] [Reference Citation Analysis]